There seems to be a bit of a hoo ha in the US between CooperVision and the FDA over the former's August recall of certain lots of Avaira toric lenses, according to various online sources including Associated Press http://finance.yahoo.com/news/CooperVision-steps-up-contact-apf-1566125735.html?x=0&.v=5 It would seem that the FDA wants a greater effort to inform consumers about the defective products, which were said to cause blurred vision because of a manufacturing residue. Another report comments that CooperVision is working to 'complete' the recall initiated on August 19. There are further reports, some of them quite sensational, suggesting that complaints of severe eye pain have led to the continued recall http://www.rttnews.com/Content/TopStories.aspx?Id=1732718. The UK is not affected and we await developments with interest after what seems like a knuckle-rapping incident on the effective management of a product recall. CooperVision says it has fully cooperated and continues to closely monitor the situation http://www.coopervision.com/about-us/pressrelease/coopervision-continues-voluntary-recall-avaira-toric-contact-lenses On a personal basis and strictly talking about non-torics, I much prefer CooperVision's Biofinity lenses to Avaira.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here